RESUMO
Objective: To compare blood pressure lowering effects of angiotensin II type I receptor blocker candesartan cilexetil in comparison with calcium channel blocker amlodipine in essential hypertensive patients
Study design: Randomized, open-labeled, prospective comparative study
Place and duration: The study was carried out in the department of pharmacology and therapeutics, Basic Medical Sciences Institute [BMSI], Jinnah Post Graduate Medical Centre [JPMC], Karachi from July 2007 to January 2008
Subjects and methods: In this study [80] newly diagnosed essential hypertensive patients were enrolled and divided into two groups [DR1] and [DR2] respectively. DR1 patients received candesartan 16mg once a day and DR2 patients received Amlodipine 10mg once a day for 3 months duration
Results: The mean systolic blood pressure of DRI was 162.23 on day 0 which decreased to 141.05 on day 90, versus DR2 which decreased from 160.12 on day 0 to 140 on day 90. The mean diastolic blood pressure decreased significantly for DR 1 group from 99.87 mmHg to 87 to 89. mmHg, versus DR2 which decreased from 98.5 to 86.25. All values of blood pressure have been taken in mmHg. The results of this study were observed statistically significant
Conclusions: Candesartan cilexetil is a newer and safer alternative for the treatment of essential hypertensive patients in comparison to conventional antihypertensive treatment